medigraphic.com
ISSN 2078-7170 (Electronic)

2023, Number 1

<< Back Next >>

CorSalud 2023; 15 (1)

Prognostic factors for complications and extent of acute myocardial infarction

López RM, Estévez RJM, Tamargo BTO, López RD, Peña FN, Jarque VVM, Pérez YLM

Language: Spanish
References: 50
Page: 11-21
PDF size: 392.06 Kb.


ABSTRACT

Introduction: Cardiovascular diseases are the leading cause of morbidity, mortality and disability worldwide. One of the most frequent acute manifestations of ischemic heart disease is acute myocardial infarction (AMI).
Objective: To determine the factors influencing the evolution of patient with acute myocardial infarction.
Method: Prospective cohort study carried out in the department of cardiology of the Hospital Clínico Quirúrgico Hermanos Ameijeiras, from March 2019 to March 2021. Ninety-five patients with a diagnosis of acute myocardial infarction were treated evaluated.
Results: Males predominated with 67.4% and mean age was 63.0±11.5 years old. Mean body mass index was 27±3.8, high blood pressure was present in 71.6% and non-ST segment elevation myocardial infraction in 54.7%. Percutaneous coronary intervention was performed in 85.3% of patients, fibrinolysis was used in 12.6% and coronary surgery only in 2.1%. Atrial fibrillation was the most common complica-tion, present in a 10.5% of cases. The peak troponin value was independently asso-ciated with the presence of complications (p=0.039, OR 1.001 [1.000-1.001]). The var-iables that remained independently associated with greater extent of the infarction were male gender (p=0.048, OR 0.369 [0.137-0.990]) and type of AMI (p=0.016. OR 3.972 [1.288-12.248]).
Conclusions: The probability of presenting complications after a myocardial infarc-tion is independently influenced by the highest troponin value. Greater extent of acute myocardial infarction was associated with males and the ST-segment elevation myocardial infraction.


REFERENCES

  1. Kahl C, Cunha KSD, Lanzoni GMM, Higashi GDC, Erdmann AL, Baggio MA. Referral and counter-referral: repercussions of coronary artery bypass graft in the perspective of Primary Care. Rev Bras Enferm. 2018;71(5):2359-66. DOI: https://doi.org/10.1590/0034-7167-2016-0598

  2. Ciruzzi M, Pramparo P, Rozlosnik J, Zylberstjn H, Delmonte H, Haquim M, et al. Hypertension and the risk of acute myocardial infarction in Argentina. The Argentine Factores de Riesgo Coronario en America del Sur (FRICAS) Investigators. Prev Cardiol. 2001;4(2):57-64. DOI: https://doi.org/10.1111/j.1520-037x.2001.00526.x

  3. Ministerio de Salud Pública. Anuario Estadístico de Salud 2020. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2021. Enlace: https://salud.msp.gob.cu/wp-content/Anuario/Anuario-2020.pdf

  4. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-69. DOI: https://doi.org/10.1093/eurheartj/ehy462

  5. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. DOI: https://doi.org/10.1093/eurheartj/ehx393

  6. Padilla-Cueto DI, Hernández-Negrín H, Pérez-Valdivia A, Barrreto-Fiu E, Ramírez-Gómez JI. Factores pronósticos de mortalidad intrahospitalaria en pacientes con infarto agudo del miocardio con elevación del segmento ST. Hospital Arnaldo Milián Castro. Villa Clara, Cuba. 2015. Med UIS. 2017;30(3):67-74. DOI: https://doi.org/10.18273/revmed.v30n3-2017007

  7. Mann DL, Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald, Tratado de Cardiología. Texto de Medicina Cardiovascular. 10ª ed. Barcelona: Elsevier; 2016.

  8. Feiring AJ, Johnson MR, Kioschos JM, Kirchner PT, Marcus ML, White CW. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation. 1987;75(5):980-7. DOI: https://doi.org/10.1161/01.cir.75.5.980

  9. Strebel I, Twerenbold R, Wussler D, Boeddinghaus J, Nestelberger T, du Fay de Lavallaz J, et al. Incremental diagnostic and prognostic value of the QRS-T angle, a 12-lead ECG marker quantifying heterogeneity of depolarization and repolarization, in patients with suspected non-ST-elevation myocardial infarction. Int J Cardiol. 2019;277:8-15. DOI: https://doi.org/10.1016/j.ijcard.2018.09.040

  10. León-Aliz E, Moreno-Martínez FL, Pérez-Fernández GA, Vega-Fleites LF, Rabassa-López-Calleja MA. Índice leuco-glucémico como marcador pronóstico de la evolución intrahospitalaria en pacientes con infarto agudo de miocardio con elevación del ST. Clin Investig Arterioscler. 2014;26(4):168-75. DOI: https://doi.org/10.1016/j.arteri.2014.01.002

  11. Novo Choy LE, Gómez García YC, Milord Fernández Y, Ramos González HL. Caracterización de pacientes con infarto miocárdico con elevación del ST complicados no trombolizados. Acta Méd Centro [Internet]. 2014 [citado 24 Abr 2022];8(1):29-36. Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/view/42/51

  12. Díaz Benítez RE, Correa Morales AM, Reyes Hernández LM, Carvajal Sánchez PA, Coronado Herrera Y, González Rivera EM. Hemoglobina glucosilada e índice leucoglucémico como determinaciones pronósticas en el síndrome coronario agudo. CorSalud [Internet]. 2016 [citado 28 Abr 2022];8(3):153-63. Disponible en: https://revcorsalud.sld.cu/index.php/cors/article/view/135/321

  13. Gaziano TA, Gaziano JM. Global evolving epidemiology, natural history and treatment trends of myocardial infarction. En: Myocardial infarction: A companion to Braunwald’s Heart disease. Amsterdam: Elsevier Inc.; 2017. p. 11-20.

  14. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of Cardiogenic Shock: A Scientific Statement from the American Heart Association. Circulation. 2017;136(16):e232-e268. DOI: https://doi.org/10.1161/cir.0000000000000525

  15. Bing R, Goodman SG, Yan AT, Fox K, Gale CP, Hyun K, et al. Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registry. Eur Heart J Qual Care Clin Outcomes. 2018;4(4):309-17. DOI: https://doi.org/10.1093/ehjqcco/qcy002

  16. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57. DOI: https://doi.org/10.1161/hypertensionaha.120.15026

  17. Summary of Revisions: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S4-S6. DOI: https://doi.org/10.2337/dc19-srev01

  18. Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: A clinical practice guideline. CMAJ. 2020;192(31):E875-E891. DOI: https://doi.org/10.1503/cmaj.191707

  19. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. DOI: https://doi.org/10.1093/eurheartj/ehz425

  20. Keith W. Huszar. Interpretación del ECG: Monitorización y 12 derivaciones. 5ª ed. Barcelona: Elsevier España; 2017.

  21. Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, et al. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement from the American Heart Association. Circulation. 2021;144(2):e16-e35. DOI: https://doi.org/10.1161/cir.0000000000000985

  22. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4-131. DOI: https://doi.org/10.1002/ejhf.2333

  23. Bradley SM, Spertus JA, Kennedy KF, Nallamothu BK, Chan PS, Patel MR, et al. Patient selection for diagnostic coronary angiography and hospital-level percutaneous coronary intervention appropriateness: insights from the National Cardiovascular Data Registry. JAMA Intern Med. 2014;174(10):1630-9. DOI: https://doi.org/10.1001/jamainternmed.2014.3904

  24. Martínez-Sellés M, Gómez Huelgas R, Abu-Assi E, Calderón A, Vidán MT. Cardiopatía isquémica crónica en el anciano. Med Clin (Barc). 2016;146(8):372.e1-e10. DOI: https://doi.org/10.1016/j.medcli.2016.01.014

  25. Arroyo-Rodríguez C, Brito-Zurita OR, Sandoval-Navarrete S, Solis-Vásquez R, Ornelas-Aguirre JM, Olea-Hernández C, Vásquez-Serna C, Castelan-Ojeda AM. Factores de riesgo para la enfermedad arterial coronaria de tres vasos en pacientes del noroeste de México. Arch Cardiol Mex. 2018;88(5):423-31. DOI: https://doi.org/10.1016/j.acmx.2018.02.009

  26. Rojas-Velázquez JM, de la Torre Fonseca LM, Giralt-Herrera A, Machín-Legón M, Leiva-Enríquez J. Complicaciones no letales en el infarto agudo de miocardio: Análisis en una unidad de cuidados coronarios. CorSalud [Internet]. 2019 [citado 28 Abr 2022];11(2):113-9. Disponible en: https://revcorsalud.sld.cu/index.php/cors/article/view/408/863

  27. Ladeiras-Lopes R, Sampaio F, Bettencourt N, Fontes-Carvalho R, Ferreira N, Leite-Moreira A, Gama V. El cociente entre la grasa abdominal visceral y la subcutánea evaluado por tomografía computarizada es un predictor independiente de mortalidad y eventos cardiacos. Rev Esp Cardiol. 2017;70(5):331-7. DOI: https://doi.org/10.1016/j.recesp.2016.09.006

  28. Mueller C, Giannitsis E, Möckel M, Huber K, Mair J, Plebani M, et al. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care. 2017;6(3):218-22. DOI: https://doi.org/10.1177/2048872616653229

  29. Möckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, et al. Editor's Choice-Rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care. 2017;6(3):212-7. DOI: https://doi.org/10.1177/2048872616653228

  30. Davis WT, Montrief T, Koyfman A, Long B. Dysrhythmias and heart failure complicating acute myocardial infarction: An emergency medicine review. Am J Emerg Med. 2019;37(8):1554-61. DOI: https://doi.org/10.1016/j.ajem.2019.04.047

  31. Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, et al. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015. Circulation. 2017;136(20):1908-19. DOI: https://doi.org/10.1161/circulationaha.117.030798

  32. Castro-Romanoshky ME, Paumier-Galano E, Abad-Loyola PL, Torres-Ferrand R, Navarro-Navarro V. Caracterización de pacientes con infarto agudo del miocardio con elevación del segmento ST, Baracoa, Guantánamo 2017-2019. Rev Inf Cient [Internet]. 2020 [citado 3 May 2022];99(4):310-320. Disponible en: https://revinfcientifica.sld.cu/index.php/ric/article/view/2984

  33. West RM, Cattle BA, Bouyssie M, Squire I, de Belder M, Fox KA, et al. Impact of hospital proportion and volume on primary percutaneous coronary intervention performance in England and Wales. Eur Heart J. 2011;32(6):706-11. DOI: https://doi.org/10.1093/eurheartj/ehq476

  34. Ahumada S, Restrepo G. Ecocardiografía en infarto agudo del miocardio. Rev Colomb Cardiol. 2014;21(3):164-73. DOI: https://doi.org/10.1016/S0120-5633(14)70274-8

  35. Belle L, Cayla G, Cottin Y, Coste P, Khalife K, Labèque JN, et al. French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data. Arch Cardiovasc Dis. 2017;110(6-7):366-78. DOI: https://doi.org/10.1016/j.acvd.2017.05.001

  36. Bhattacharyya PJ, Vijapur S, Bhattacharyya AK. A Study of cardiovascular risk factors correlation with the angiographic severity of coronary artery disease using Syntax score. IOSR-JDMS. 2016;15(1):21-8. Enlace: http://www.iosrjournals.org/iosr-jdms/papers/Vol15-issue1/Version-4/F015142128.pdf

  37. Kappetein AP, Head SJ, Morice MC, Banning AP, Serruys PW, Mohr FW, et al. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg. 2013;43(5):1006-13. DOI: https://doi.org/10.1093/ejcts/ezt017

  38. Valdés Ramos ER, Rivera Chávez M, Bencosme Rodríguez N. Comportamiento del infarto agudo de miocardio en personas con diabetes mellitus de la provincia Granma. Rev Cubana Endocrinol [Internet]. 2012 [citado 30 Abr 2022];23(2):128-38. Disponible en: http://scielo.sld.cu/pdf/end/v23n2/end03212.pdf

  39. Santos Medina M, Barreiro García A, García González RC, Barreiro Noa AE. Factores de riesgo de mortalidad hospitalaria post infarto agudo de miocardio. Rev Cuban Cardiol [Internet]. 2017 [citado 8 May 2022];23(3). Disponible en: https://revcardiologia.sld.cu/index.php/revcardiologia/article/view/710/pdf_91

  40. Ortega Palomino ME, Orellana Marín FJ. Factores predictivos de mortalidad intrahospitalaria en infarto agudo de miocardio con elevación del segmento ST, estudio realizado en el Hospital de Especialidades Teodoro Maldonado Carbo durante el período 2013-2017 [Tesis]. Guayaquil (Ecuador): Universidad de Guayaquil [Internet]; 2018 [citado 8 May 2022]. Disponible en: http://repositorio.ug.edu.ec/handle/redug/31114

  41. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102(17):2031-7. DOI: https://doi.org/10.1161/01.cir.102.17.2031

  42. Batra G, Svennblad B, Held C, Jernberg T, Johanson P, Wallentin L, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016;102(12):926-33. DOI: https://doi.org/10.1136/heartjnl-2015-308678

  43. Levy B, Bastien O, Bendjelid K, Cariou A, Chouihed T, Combes A, et al. Experts’ recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care [Internet]. 2015 [citado 30 Abr 2022];5(1):17. Disponible en: https://doi.org/10.1186/s13613-015-0052-1

  44. Hajjar LA, Teboul JL. Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art. Crit Care [Internet]. 2019 [citado 30 Abr 2022];23(1):76. Disponible en: https://doi.org/10.1186/s13054-019-2368-y

  45. Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med. 2016;129(4):446.e5-446.e21. DOI: https://doi.org/10.1016/j.amjmed.2015.11.006

  46. Santos Medina M, Ricardo Mora E. Factores de riesgo de rotura cardiaca posterior al infarto del miocárdico. Rev Cub Med Int Emerg [Internet]. 2017 [citado 3 May 2022];16(4):85-92. Disponible en: https://revmie.sld.cu/index.php/mie/article/view/85-92/pdf_68

  47. Mohammad MA, Koul S, Smith JG, Noc M, Lang I, Holzer M, et al. Predictive Value of High-Sensitivity Troponin T for Systolic Dysfunction and Infarct Size (Six Months) After ST-Elevation Myocardial Infarction. Am J Cardiol. 2018;122(5):735-43. DOI: https://doi.org/10.1016/j.amjcard.2018.05.005

  48. Montisci R, Ruscazio M, Tona F, Corbetti F, Sarais C, Marchetti MF, et al. Coronary flow reserve is related to the extension and transmurality of myocardial necrosis and predicts functional recovery after acute myocardial infarction. Echocardiography. 2019;36(5):844-53. DOI: https://doi.org/10.1111/echo.14337

  49. Tiller C, Reindl M, Holzknecht M, Klapfer M, Beck A, Henninger B, et al. Biomarker assessment for early infarct size estimation in ST-elevation myocardial infarction. Eur J Intern Med. 2019;64:57-62. DOI: https://doi.org/10.1016/j.ejim.2019.03.001

  50. Boeddinghaus J, Twerenbold R, Nestelberger T, Koechlin L, Wussler D, Meier M, et al. Clinical Use of a New High-Sensitivity Cardiac Troponin I Assay in Patients with Suspected Myocardial Infarction. Clin Chem. 2019;65(11):1426-36. DOI: https://doi.org/10.1373/clinchem.2019.304725




2020     |     www.medigraphic.com